El Asmar, Antoine http://orcid.org/0000-0002-6635-4616
Demetter, Pieter
Fares, Fahd
Sclafani, Francesco
Hendlisz, Alain
Donckier, Vincent
Vermeulen, Peter
Liberale, Gabriel
Article History
Received: 9 November 2022
Accepted: 2 January 2023
First Online: 8 February 2023
Disclosures
: Dr. Francesco Sclafani reports: Consultancy, advisory roles, honoraria—AMAL Therapeutics, Bayer, BMS, Dragonfly Therapeutics, Merck, Nordic Pharma, Roche, Servier; research funding (institute)—Amgen, Astra Zeneca, Bayer, BMS, Roche, Sanofi; travel grants: Amgen, Bayer, Lilly, Servier.